[1]
Baker, L., Crowell, J., DeVall, K. and Lanier, C. 2024. Prescription drug monitoring programs in the United States: A review of system characteristics and their impact on opioid-related harms. Drug Court Review. 3, (Aug. 2024), 3–27.